2021
DOI: 10.1136/jmedgenet-2021-107942
|View full text |Cite
|
Sign up to set email alerts
|

Expanding the phenotype of SPARC-related osteogenesis imperfecta: clinical findings in two patients with pathogenic variants in SPARC and literature review

Abstract: BackgroundSecreted protein, acidic, cysteine rich (SPARC)-related osteogenesis imperfecta (OI), also referred to as OI type XVII, was first described in 2015, since then there has been only one further report of this form of OI. SPARC is located on chromosome 5 between bands q31 and q33. The encoded protein is necessary for calcification of the collagen in bone, synthesis of extracellular matrix and the promotion of changes to cell shape.MethodsWe describe a further two patients with previously unreported homo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 18 publications
1
3
0
Order By: Relevance
“…Delayed motor development with neuromuscular weakness, scoliosis and multiple compression fractures as common phenotypes in SPARC gene mutation have been reported recently and expand the phenotypic spectrum of similar neuromuscular patterns with a presumed diagnosis of myopathy [3,4]. Our child's significant motor delay and hypotonia through grade 3 power are consistent with previous reports.…”
supporting
confidence: 90%
“…Delayed motor development with neuromuscular weakness, scoliosis and multiple compression fractures as common phenotypes in SPARC gene mutation have been reported recently and expand the phenotypic spectrum of similar neuromuscular patterns with a presumed diagnosis of myopathy [3,4]. Our child's significant motor delay and hypotonia through grade 3 power are consistent with previous reports.…”
supporting
confidence: 90%
“…The BGN also directly collaborates with TNF-α and RANKL to control the bone mass and osteoclastogenesis ( Kram et al, 2017 ). The SPARC is required for the calcification of collagen in bone, and is also involved in maintaining cell shape ( Durkin et al, 2022 ). COL1A2 encodes pro-alpha2 chain of type I collagen, and its mutations cause the osteogenesis imperfecta ( Makitie et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Both type XVII and type XVIII OI patients share a history of repeated fractures and exhibit a clinical severity ranging from moderate to severe. , Type XVII is characterized by impaired lower-extremity muscular strength and delayed speech or motor development. , On the other hand, type XVIII OI presents congenital lower extremity curvature, vertebral collapse, and numerous fractures. Patients with type XX OI have mutations associated with the WNT1 signaling pathway, similar to those seen in type XV patients …”
Section: Oi Typologymentioning
confidence: 99%